Will Mifepristone Be Recalled If Texas Ruling Remains In Effect? Biopharma Leaders Back FDA

 
• By Brenda Sandburg
  
Bridge and uncertainty
The mifepristone ruling creates uncertainty for the FDA and industry. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership